Inovio Pharmaceuticals Statistics
Total Valuation
BMV:INO has a market cap or net worth of MXN 1.85 billion. The enterprise value is 1.16 billion.
Market Cap | 1.85B |
Enterprise Value | 1.16B |
Important Dates
The last earnings date was Friday, August 8, 2025.
Earnings Date | Aug 8, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 53.14M |
Shares Outstanding | n/a |
Shares Change (YoY) | +41.82% |
Shares Change (QoQ) | +0.56% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 52.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 537.45 |
PB Ratio | 3.43 |
P/TBV Ratio | 3.43 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.70 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -0.65 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.37.
Current Ratio | 1.66 |
Quick Ratio | 1.53 |
Debt / Equity | 0.37 |
Debt / EBITDA | n/a |
Debt / FCF | -0.11 |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -140.12% and return on invested capital (ROIC) is -80.46%.
Return on Equity (ROE) | -140.12% |
Return on Assets (ROA) | -59.30% |
Return on Invested Capital (ROIC) | -80.46% |
Return on Capital Employed (ROCE) | -262.37% |
Revenue Per Employee | 25,661 |
Profits Per Employee | -12.35M |
Employee Count | 134 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.67% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -78.67% |
50-Day Moving Average | 32.74 |
200-Day Moving Average | 46.84 |
Relative Strength Index (RSI) | 61.23 |
Average Volume (20 Days) | 141 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.03 |
Income Statement
In the last 12 months, BMV:INO had revenue of MXN 3.44 million and -1.66 billion in losses. Loss per share was -48.82.
Revenue | 3.44M |
Gross Profit | -1.17B |
Operating Income | -1.81B |
Pretax Income | -1.66B |
Net Income | -1.66B |
EBITDA | -1.78B |
EBIT | -1.81B |
Loss Per Share | -48.82 |
Balance Sheet
The company has 896.70 million in cash and 200.99 million in debt, giving a net cash position of 695.70 million.
Cash & Cash Equivalents | 896.70M |
Total Debt | 200.99M |
Net Cash | 695.70M |
Net Cash Per Share | n/a |
Equity (Book Value) | 538.04M |
Book Value Per Share | 14.65 |
Working Capital | 395.82M |
Cash Flow
In the last 12 months, operating cash flow was -1.79 billion and capital expenditures -1.70 million, giving a free cash flow of -1.79 billion.
Operating Cash Flow | -1.79B |
Capital Expenditures | -1.70M |
Free Cash Flow | -1.79B |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -52,568.64% |
Pretax Margin | -48,131.35% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BMV:INO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -41.82% |
Shareholder Yield | n/a |
Earnings Yield | -89.56% |
FCF Yield | -96.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333333.
Last Split Date | Jan 25, 2024 |
Split Type | Reverse |
Split Ratio | 0.0833333333 |
Scores
BMV:INO has an Altman Z-Score of -38.83. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -38.83 |
Piotroski F-Score | n/a |